Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
- PMID: 12515714
- DOI: 10.1182/blood-2002-11-3387
Mutations of the BCL6 proto-oncogene disrupt its negative autoregulation in diffuse large B-cell lymphoma
Abstract
The BCL6 proto-oncogene encodes a transcriptional repressor whose expression is deregulated by chromosomal translocations in approximately 40% of diffuse large B-cell lymphomas (DLBCLs). The BCL6 regulatory sequences are also _targeted by somatic hypermutation in germinal center (GC) B cells and in a fraction of all GC-derived lymphomas. However, the functional consequences of these mutations are unknown. Here we report that a subset of mutations specifically associated with DLBCL causes deregulated BCL6 transcription. These mutations affect 2 adjacent BCL6 binding sites located within the first noncoding exon of the gene, and they prevent BCL6 from binding its own promoter, thereby disrupting its negative autoregulatory circuit. These alterations were found in approximately 16% of DLBCLs devoid of chromosomal translocations involving the BCL6 locus, but they were not found in normal GC B cells. This study establishes a novel mechanism for BCL6 deregulation and reveals a broader involvement of this gene in DLBCL pathogenesis.
Similar articles
-
BCL-6 in diffuse large-cell lymphomas.Important Adv Oncol. 1996:139-48. Important Adv Oncol. 1996. PMID: 8791133 Review. No abstract available.
-
Primary mediastinal B-cell lymphoma: hypermutation of the BCL6 gene _targets motifs different from those in diffuse large B-cell and follicular lymphomas.Haematologica. 2004 Sep;89(9):1091-9. Haematologica. 2004. PMID: 15377470
-
BCL6 suppression of BCL2 via Miz1 and its disruption in diffuse large B cell lymphoma.Proc Natl Acad Sci U S A. 2009 Jul 7;106(27):11294-9. doi: 10.1073/pnas.0903854106. Epub 2009 Jun 23. Proc Natl Acad Sci U S A. 2009. PMID: 19549844 Free PMC article.
-
[Bcl-6: a protooncogene co-involved in B-lymphocyte differentiation and in the pathogenesis of diffuse, large-cell non-Hodgkin's lymphomas of the B phenotype].Pathologica. 1998 Feb;90(1):81-2. Pathologica. 1998. PMID: 9628984 Review. Italian. No abstract available.
-
The LAZ3/BCL6 oncogene encodes a sequence-specific transcriptional inhibitor: a novel function for the BTB/POZ domain as an autonomous repressing domain.Cell Growth Differ. 1995 Dec;6(12):1495-503. Cell Growth Differ. 1995. PMID: 9019154
Cited by
-
Histone acetyltransferases and histone deacetylases in B- and T-cell development, physiology and malignancy.Genes Cancer. 2015 May;6(5-6):184-213. doi: 10.18632/genesandcancer.65. Genes Cancer. 2015. PMID: 26124919 Free PMC article. Review.
-
BCL6--regulated by AhR/ARNT and wild-type MEF2B--drives expression of germinal center markers MYBL1 and LMO2.Haematologica. 2015 Jun;100(6):801-9. doi: 10.3324/haematol.2014.120048. Epub 2015 Mar 13. Haematologica. 2015. PMID: 25769544 Free PMC article.
-
Dysregulation of miRNAs in DLBCL: Causative Factor for Pathogenesis, Diagnosis and Prognosis.Diagnostics (Basel). 2021 Sep 22;11(10):1739. doi: 10.3390/diagnostics11101739. Diagnostics (Basel). 2021. PMID: 34679437 Free PMC article. Review.
-
Genetic alterations in B cell lymphoma subtypes as potential biomarkers for noninvasive diagnosis, prognosis, therapy, and disease monitoring.Turk J Biol. 2020 Feb 17;44(1):1-14. doi: 10.3906/biy-1908-23. eCollection 2020. Turk J Biol. 2020. PMID: 32123491 Free PMC article.
-
Reciprocal occupancy of BCL6 and STAT5 on Growth Hormone _target genes: contrasting transcriptional outcomes and promoter-specific roles of p300 and HDAC3.Mol Cell Endocrinol. 2014 Sep;395(1-2):19-31. doi: 10.1016/j.mce.2014.07.020. Epub 2014 Aug 1. Mol Cell Endocrinol. 2014. PMID: 25088465 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
